Skip to search formSkip to main contentSkip to account menu

BMY-40481

National Institutes of Health

Related topics

Related topics

2 relations
Etopophos

Broader (1)

etoposide phosphate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Clinical and pharmacokinetic overview of parenteral etoposide phosphate
Etoposide phosphate (Etopophos, BMY-40481) is a water-soluble derivative of the widely used podophyllotoxin etoposide (VP-16… 
1995
1995
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481).
1994
1994
Etoposide- and BMY-40481-Induced Sensory Neuropathy in Mice
The effects of high toxic doses of the anticancer drugs, etoposide and its phosphate derivative, BMY-40481, on the nervous system… 
1993
1993
Phase I clinical study and pharmacological evaluation of oral etoposide phosphate (BMY-40481)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)